Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
For You
Following
My Playlist
Explore more
Trending
Movie
Music
Gaming
Sports
News
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
The Long-Term Efficacy of Inebilizumab in NMOSD: Bruce Cr
…
Apr 24, 2021
neurologylive.com
ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
20 views
1 week ago
diabetesincontrol.com
1:12:54
Understanding Clinical Trials For Autoimmune Encephalitis
303 views
Nov 16, 2023
YouTube
International Autoimmune Encephalitis Society
1:59
Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment
…
351 views
Aug 21, 2014
YouTube
Targeted Oncology
7:37
Zanidatamab for HER2-amplified, unresectable, locally advanced or
…
899 views
Jun 12, 2023
YouTube
The Lancet
0:42
AstraZeneca’s Immunotherapy Imjudo (tremelimumab) Wins FDA
…
2.8K views
Oct 28, 2022
YouTube
Xtalks
3:31
Approved Treatments for Neuromyelitis Optica Spectrum Di
…
2.4K views
Jun 30, 2020
YouTube
CheckRare
3:10
Donanemab: breakthrough therapy designation based on TRAILBLAZ
…
1.9K views
Sep 1, 2021
YouTube
VJDementia
10:34
My First Obinutuzumab (Gazyva) Infusion
2.4K views
Mar 23, 2018
YouTube
Todd Dunn
2:15
How Breakthroughs in Immunotherapy are Helping Non-
…
12.3K views
Jun 23, 2023
YouTube
Cancer Research Institute
7:00
Expert report on neoadjuvant immune checkpoint inhibitors for
…
1.3K views
Sep 21, 2022
YouTube
European Society for Medical Oncology (ESMO)
6:10
PD-1 inhibitor pembrolizumab shows promising clinical activity f
…
1.1K views
Feb 9, 2015
YouTube
ecancer
9:31
LEQEMBI ® (lecanemab-irmb) Now Approved Via Traditional U.S FD
…
221 views
Aug 11, 2023
YouTube
HPR
6:07
Sequential use of immune checkpoint inhibitors in renal cell
…
727 views
Jun 5, 2023
YouTube
The Lancet
6:10
Nivolumab: A New Standard-of-Care
6.3K views
Feb 20, 2017
YouTube
OncLive
14:00
ASCO 2021 Lung Recap: IMpower010: Atezolizumab after C
…
621 views
Jan 15, 2022
YouTube
GRACE - Global Resource for Advancing Canc…
17:23
Episode 6: AANTV at the 2023 Annual Meeting - American Acade
…
887 views
Apr 26, 2023
YouTube
AANChannel
3:17
Nivolumab With Ipilimumab for Small Cell Lung Cancer
1.6K views
Jul 6, 2017
YouTube
Targeted Oncology
4:17
Highlights on amivantamab after progression on osimertinib in EG
…
1.6K views
Oct 23, 2023
YouTube
European Society for Medical Oncology (ESMO)
52:55
Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - L
…
361K views
Sep 18, 2022
YouTube
The Apples
7:44
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C
…
2.8K views
Feb 20, 2018
YouTube
BeaconMedIC
0:58
FDA Approves Mirikizumab, a Promising Induction and Maintena
…
324 views
Oct 29, 2023
YouTube
Global Health Today
2:37
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced br
…
2K views
Sep 9, 2022
YouTube
European Society for Medical Oncology (ESMO)
2:17
Choosing between inotuzumab ozogamicin and blinatumomab in
…
651 views
Jul 4, 2022
YouTube
VJHemOnc – Video Journal of Hematology & H…
24:19
Neuromyelitis Optica by Dr. Ani Papiashvili
476 views
2 months ago
YouTube
AMIQT Rotations
Satralizumab: A Review in Neuromyelitis Optica Spectrum Di
…
Mar 18, 2023
springer.com
15:44
Treatment Effect on Patient Pain and Quality of Life in Neuromyeliti
…
222 views
3 months ago
YouTube
CheckRare
55:12
Selecting and Sequencing Targeted and Immunotherapy Regimens fo
…
2.2K views
Jan 4, 2022
YouTube
PeerView Oncology
5:43
Inebilizumab Treatment in Newly Diagnosed NMOSD Patients
681 views
Apr 20, 2022
YouTube
CheckRare
6:49
Lenvatinib plus pembrolizumab versus SoC for previously treated
…
194 views
Jul 7, 2023
YouTube
ecancer
See more videos
More like this
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Invisible focusable element for fixing accessibility issue
Feedback
Feedback